BioSpace News Archive

Stryker announced that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with autoimmune diseases, announced that six abstracts were accepted for poster presentation at the 19th Annual Congress of the European Crohn’s and Colitis Organisation.

NewAmsterdam Pharma Company N.V. announced the appointment of William H. Lewis, J.D., M.B.A., as Chair of its Board of Directors.

OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, being held January 8-11, 2024 at Westin St. Francis hotel in San Francisco.

Wave Life Sciences Ltd. announced key 2024 milestones across its clinical programs, growing pipeline, and leading RNA medicines platform.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that it has acquired Boston Orthotics & Prosthetics, a leader in pediatric orthotic management for over 50 years.

Denali Therapeutics Inc. (Nasdaq: DNLI) today announced program progress and expected milestones for 2024, which Chief Executive Officer, Ryan Watts, Ph.D., will highlight during a corporate presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, at 10:30 a.m. Pacific Time.

Praxis Precision Medicines, Inc. provided an update on its portfolio and planned key milestones in 2024.

YS Biopharma Co., Ltd. announced that the Company’s Board of Directors has approved Ms. Rui Yu as the new Chairperson of its Audit Committee, as a member of its Compensation Committee, and as a member of the Nominating and Corporate Governance Committee on January 7, 2024, with immediate effect.

Blueprint Medicines Corporation (Nasdaq: BPMC) today outlined its 2024 corporate strategy to deliver accelerated revenue growth, sustainable research and development, and a clear path to profitability.